Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.
Advisers to the Food and Drug Administration voted 14-2 on Wednesday that all new diabetes drugs should undergo longer studies to assure they don't increase risks of heart problems. The agency currently doesn't screen for heart risks associated with diabetes drugs.
1,289,618 pageviews
19,430 new posts 879 new members last month alone, Join
Us 
FDA panel urges more testing for diabetes drugs 
Linear Mode
